RTTNews | Jan 28, 2021 09:51AM EST

09:51 Thursday, January 28, 2021 (RTTNews.com) - Shares of Monopar Therapeutics Inc. (MNPR) are currently gaining over 55% despite no stock-related news to drive the shares.

MNPR is currently trading at $10.35, up $3.71 or 55.87%, on the Nasdaq.

Monopar Therapeutics, a biopharmaceutical company, engages in developing proprietary therapeutics to enhance clinical outcomes for cancer patients in the US.

Read the original article on RTTNews ( https://www.rttnews.com/3164530/stock-alert-monopar-therapeutics-jumps-55.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved